ÂÜÀòÂÒÂ×

Patrick Zhang is an experienced investor in the global healthcare and biotechnology sectors, currently serving as an Investor at Horizons Ventures since July 2016. In addition to investing, Patrick holds several board observer positions with companies including Juvena Therapeutics, Kimia Therapeutics, Chemify Limited, and Kelonia Therapeutics, as well as a board membership at Theradaptive. Notable investments include BioLoomics, Inc., Manifold Bio, Concerto Biosciences, and Deepcell, Inc. Patrick Zhang's academic background includes an M.B.A. from Columbia Business School, a B.S. in Chemical Engineering from UCLA, and a certificate in Project Management from Caltech.